BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17027516)

  • 1. The newest interleukins: recent additions to the ever-growing cytokine family.
    Chen Q; Carroll HP; Gadina M
    Vitam Horm; 2006; 74():207-28. PubMed ID: 17027516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activity of interleukins-28 and -29: comparison with type I interferons.
    Meager A; Visvalingam K; Dilger P; Bryan D; Wadhwa M
    Cytokine; 2005 Jul; 31(2):109-18. PubMed ID: 15899585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-28, IL-29 and their class II cytokine receptor IL-28R.
    Sheppard P; Kindsvogel W; Xu W; Henderson K; Schlutsmeyer S; Whitmore TE; Kuestner R; Garrigues U; Birks C; Roraback J; Ostrander C; Dong D; Shin J; Presnell S; Fox B; Haldeman B; Cooper E; Taft D; Gilbert T; Grant FJ; Tackett M; Krivan W; McKnight G; Clegg C; Foster D; Klucher KM
    Nat Immunol; 2003 Jan; 4(1):63-8. PubMed ID: 12469119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases.
    Akdis M; Aab A; Altunbulakli C; Azkur K; Costa RA; Crameri R; Duan S; Eiwegger T; Eljaszewicz A; Ferstl R; Frei R; Garbani M; Globinska A; Hess L; Huitema C; Kubo T; Komlosi Z; Konieczna P; Kovacs N; Kucuksezer UC; Meyer N; Morita H; Olzhausen J; O'Mahony L; Pezer M; Prati M; Rebane A; Rhyner C; Rinaldi A; Sokolowska M; Stanic B; Sugita K; Treis A; van de Veen W; Wanke K; Wawrzyniak M; Wawrzyniak P; Wirz OF; Zakzuk JS; Akdis CA
    J Allergy Clin Immunol; 2016 Oct; 138(4):984-1010. PubMed ID: 27577879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-23 and IL-27: new members of the growing family of IL-12-related cytokines with important implications for therapeutics.
    Cordoba-Rodriguez R; Frucht DM
    Expert Opin Biol Ther; 2003 Aug; 3(5):715-23. PubMed ID: 12880372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27.
    Beadling C; Slifka MK
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):15-24. PubMed ID: 16642253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties.
    Witte K; Witte E; Sabat R; Wolk K
    Cytokine Growth Factor Rev; 2010 Aug; 21(4):237-51. PubMed ID: 20655797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32).
    Conti P; Youinou P; Theoharides TC
    Autoimmun Rev; 2007 Jan; 6(3):131-7. PubMed ID: 17289547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 21: a cytokine/cytokine receptor system that has come of age.
    Leonard WJ; Zeng R; Spolski R
    J Leukoc Biol; 2008 Aug; 84(2):348-56. PubMed ID: 18467657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stepwise regulation of TH1 responses in autoimmunity: IL-12-related cytokines and their receptors.
    Becker C; Wirtz S; Neurath MF
    Inflamm Bowel Dis; 2005 Aug; 11(8):755-64. PubMed ID: 16043992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 innate immune responses and the natural helper cell.
    Koyasu S; Moro K
    Immunology; 2011 Apr; 132(4):475-81. PubMed ID: 21323663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses.
    Wang YH; Liu YJ
    Clin Exp Allergy; 2009 Jun; 39(6):798-806. PubMed ID: 19400908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the role of cytokines in asthma.
    Renauld JC
    J Clin Pathol; 2001 Aug; 54(8):577-89. PubMed ID: 11477111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New interleukins: are there any more?
    Gadina M; Ferguson PR; Johnston JA
    Curr Opin Infect Dis; 2003 Jun; 16(3):211-7. PubMed ID: 12821810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into IL-29: Emerging role in inflammatory autoimmune diseases.
    Wang JM; Huang AF; Xu WD; Su LC
    J Cell Mol Med; 2019 Dec; 23(12):7926-7932. PubMed ID: 31578802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro.
    Srinivas S; Dai J; Eskdale J; Gallagher GE; Megjugorac NJ; Gallagher G
    Immunology; 2008 Dec; 125(4):492-502. PubMed ID: 18547367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1 Superfamily Members and Periodontal Diseases.
    Papathanasiou E; Conti P; Carinci F; Lauritano D; Theoharides TC
    J Dent Res; 2020 Dec; 99(13):1425-1434. PubMed ID: 32758110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of IL-38 and its related cytokines in inflammation.
    Yuan X; Peng X; Li Y; Li M
    Mediators Inflamm; 2015; 2015():807976. PubMed ID: 25873772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12 and IL-23: master regulators of innate and adaptive immunity.
    Langrish CL; McKenzie BS; Wilson NJ; de Waal Malefyt R; Kastelein RA; Cua DJ
    Immunol Rev; 2004 Dec; 202():96-105. PubMed ID: 15546388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease.
    Sun L; He C; Nair L; Yeung J; Egwuagu CE
    Cytokine; 2015 Oct; 75(2):249-55. PubMed ID: 25796985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.